Chart-Typ:
Zeitraum:
| T1 Energy Inc.: T1 Energy Reports Second Quarter 2026 Results | AUSTIN, Texas and NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ("T1," "T1 Energy," or the "Company") today reported financial and operating results for the second quarter... ► Artikel lesen |
| T1 Energy Inc.: T1 and Clearway Energy Group Execute Strategic Offtake Deal | AUSTIN, Texas and NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ("T1," "T1 Energy," or the "Company") announced this morning a contract to supply independent power producer Clearway... ► Artikel lesen |
| T1 Energy Inc.: T1 Announces Preliminary Results for Second Quarter 2026 | AUSTIN, Texas and NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ("T1," "T1 Energy," or the "Company") has announced preliminary financial and operating results for the second... ► Artikel lesen |
| Niu Technologies Announces Unaudited Second Quarter 2026 Financial Results | -- Second Quarter Revenues of RMB 1,440.4 million, up 14.7% year over year -- Second Quarter Net Loss of RMB 102.2 million, compared with Net Income of RMB 5.9 million in the same period of 2025 BEIJING... ► Artikel lesen |
| Niu Technologies Provides Second Quarter 2026 Sales Volume Update | BEIJING, July 03, 2026 (GLOBE NEWSWIRE) -- Niu Technologies ("NIU" or "the Company") (NASDAQ: NIU), the world's leading provider of smart urban mobility solutions, today provided its sales volume... ► Artikel lesen |
| Niu Technologies Announces Unaudited First Quarter 2026 Financial Results | -- First Quarter Revenues of RMB 909.5 million, up 33.4% year over year -- First Quarter Net Loss of RMB 93.9 million, compared with RMB 38.8 million in the same period of 2025 BEIJING, May 18, 2026... ► Artikel lesen |
| Sangamo Therapeutics, Inc.: Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones | PTC Therapeutics to purchase Fabry disease program, isaralgagene civaparvovec Lilly to purchase capsid delivery, zinc finger and modular integrase (MINT) platforms and prion disease program Proposed... ► Artikel lesen |
| Sangamo Announces Asset Sale Agreements; Commences Chapter 11 Proceedings | INDIANAPOLIS (dpa-AFX) - Sangamo Therapeutics has entered into two separate asset sale agreements, one with Eli Lilly and Company (LLY) for Sangamos capsid delivery platform, zinc finger platform... ► Artikel lesen |
| Sangamo Therapeutics, Inc.: Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas | Sangamo intends to complete asset sale transactions through a voluntary Chapter 11 reorganization, in an effort to maximize business value for all stakeholders Lilly and Astellas to serve as "stalking... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GIFTIFY INC finden Sie auf Wallstreet Online.